Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far?
- PMID: 34595396
- PMCID: PMC8479963
- DOI: 10.1099/acmi.0.000245
Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far?
Erratum in
-
Corrigendum: Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far?Access Microbiol. 2022 Jan 12;4(1):000294. doi: 10.1099/acmi.0.000294. eCollection 2022. Access Microbiol. 2022. PMID: 35252747 Free PMC article.
Abstract
Tuberculosis (TB) affects around 10 million people worldwide in 2019. Approximately 3.4 % of new TB cases are multidrug-resistant. The gold standard method for detecting Mycobacterium tuberculosis, which is the aetiological agent of TB, is still based on microbiological culture procedures, followed by species identification and drug sensitivity testing. Sputum is the most commonly obtained clinical specimen from patients with pulmonary TB. Although smear microscopy is a low-cost and widely used method, its sensitivity is 50-60 %. Thus, owing to the need to improve the performance of current microbiological tests to provide prompt treatment, different methods with varied sensitivity and specificity for TB diagnosis have been developed. Here we discuss the existing methods developed over the past 20 years, including their strengths and weaknesses. In-house and commercial methods have been shown to be promising to achieve rapid diagnosis. Combining methods for mycobacterial detection systems demonstrates a correlation of 100 %. Other assays are useful for the simultaneous detection of M. tuberculosis species and drug-related mutations. Novel approaches have also been employed to rapidly identify and quantify total mycobacteria RNA, including assessments of global gene expression measured in whole blood to identify the risk of TB. Spoligotyping, mass spectrometry and next-generation sequencing are also promising technologies; however, their cost needs to be reduced so that low- and middle-income countries can access them. Because of the large impact of M. tuberculosis infection on public health, the development of new methods in the context of well-designed and -controlled clinical trials might contribute to the improvement of TB infection control.
Keywords: diagnosis; drug-resistant tuberculosis; nucleic acid amplification techniques; tuberculosis.
© 2021 The Authors.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
[Clinical application of testing methods on acid-fast bacteria].Kekkaku. 2005 Feb;80(2):95-111. Kekkaku. 2005. PMID: 15920982 Japanese.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
[Mycobacterial tests].Kekkaku. 2008 Jan;83(1):43-59. Kekkaku. 2008. PMID: 18283915 Japanese.
-
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.J Clin Microbiol. 2014 Apr;52(4):1052-9. doi: 10.1128/JCM.02639-13. Epub 2014 Jan 15. J Clin Microbiol. 2014. PMID: 24430455 Free PMC article.
-
Exploring tuberculosis by molecular tests on DNA isolated from smear microscopy slides.Int J Infect Dis. 2017 Mar;56:248-252. doi: 10.1016/j.ijid.2016.12.005. Epub 2016 Dec 12. Int J Infect Dis. 2017. PMID: 27979786 Review.
Cited by
-
Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs.Pathogens. 2024 Nov 28;13(12):1045. doi: 10.3390/pathogens13121045. Pathogens. 2024. PMID: 39770305 Free PMC article. Review.
-
Disseminated Tuberculosis of the Lungs, Brain, Pleurae, Mediastinal Lymphadenopathy, and Elbow Joint in an Immunocompetent Indian Female: A First-of-Its-Type Case.Cureus. 2024 Apr 25;16(4):e58974. doi: 10.7759/cureus.58974. eCollection 2024 Apr. Cureus. 2024. PMID: 38800244 Free PMC article.
-
Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals.IJTLD Open. 2025 Jan 1;2(1):26-32. doi: 10.5588/ijtldopen.24.0410. eCollection 2025 Jan. IJTLD Open. 2025. PMID: 39802227 Free PMC article.
-
Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches.Diseases. 2024 Sep 3;12(9):202. doi: 10.3390/diseases12090202. Diseases. 2024. PMID: 39329871 Free PMC article. Review.
-
Quantum Dot-Based Nanosensors for In Vitro Detection of Mycobacterium tuberculosis.Nanomaterials (Basel). 2024 Sep 26;14(19):1553. doi: 10.3390/nano14191553. Nanomaterials (Basel). 2024. PMID: 39404280 Free PMC article. Review.
References
-
- Dockrell HM, Weir RE. Whole blood cytokine assays-a new generation of diagnostic tests for tuberculosis? Int J Tuberc Lung Dis. 1998;2:441–442. - PubMed
-
- WHO Global tuberculosis report 2019. Geneva. 2019
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous